Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

185
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
185
Relative Risk01:12

Relative Risk

376
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
376
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

163
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
163
Hazard Ratio01:12

Hazard Ratio

266
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
266
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

280
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
280
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

713
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
713

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigations of a multi-objective diet optimization model including human health, environment, and observed dietary intake.

Food & nutrition research·2026
Same author

Methods for the detection of anisakid material in different food matrices: A systematic review.

Food and waterborne parasitology·2026
Same author

WHO estimates of the global, regional, and national foodborne burdens of 14 invasive parasitic diseases, 2000-21: an updated data synthesis.

The Lancet. Global health·2026
Same author

WHO estimates of the global, regional, and national disease burden of nine foodborne chemicals, 2000-21: an updated data synthesis.

The Lancet. Global health·2026
Same author

WHO estimates of the global, regional, and national burden of eight foodborne non-diarrhoeal enteric disease hazards, 2000-21: an updated data synthesis.

The Lancet. Global health·2026
Same author

WHO estimates of the global, regional, and national burden of 14 foodborne diarrhoeal enteric hazards, 2000-21: an updated data synthesis.

The Lancet. Global health·2026

Related Experiment Video

Updated: Sep 21, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Estimating risk factor attributable burden - challenges and potential solutions when using the comparative risk

Dietrich Plass1, Henk Hilderink2, Heli Lehtomäki3,4

  • 1German Environment Agency, Section Exposure Assessment and Environmental Health Indicators, Berlin, Germany. dietrich.plass@uba.de.

Archives of Public Health = Archives Belges De Sante Publique
|May 27, 2022
PubMed
Summary

Comparative risk assessment (CRA) quantifies disease burden from risk factors but faces data challenges. Addressing these methodological issues ensures accurate public health insights.

Keywords:
Burden of disease (BoD)Comparative risk assessment (CRA)Disability-adjusted life years (DALY)Health impact assessment (HIA)Population health

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Related Experiment Videos

Last Updated: Sep 21, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

Area of Science:

  • Epidemiology
  • Public Health
  • Biostatistics

Background:

  • Burden of disease analyses are crucial for understanding population health.
  • Comparative Risk Assessment (CRA) is a key methodology for attributing disease burden to risk factors.
  • Challenges in CRA methodology can impact the accuracy of health status overviews.

Purpose of the Study:

  • To identify and address key challenges in the Comparative Risk Assessment (CRA) methodology.
  • To discuss methods for handling identified CRA challenges.
  • To differentiate CRA from Health Impact Assessments (HIA).

Main Methods:

  • Review and analysis of existing CRA methodologies.
  • Illustration of challenges with practical examples.
  • Discussion of potential solutions and best practices for CRA.

Main Results:

  • CRAs are data-intensive, requiring robust exposure-response relationships.
  • Defining minimal risk exposure levels and accounting for uncertainty are significant challenges.
  • Ensuring consistency in data, formulas, and temporal dimensions is critical for accurate Population Attributable Fractions (PAFs).

Conclusions:

  • Transparent reporting of CRA input and process data is essential.
  • Well-established evidence of causality is necessary for informing public health practice.